Eltrombopag (Revolade,Eltromdx)

Eltrombopag Olamine Tablets are a thrombopoietin receptor agonist and a hemostatic agent.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Eltrombopag Drug News

FDA Approves Promacta as First-Line Therapy for Aplastic Anemia

Overview of Severe Aplastic Anemia (SAA)Severe aplastic anemia (SAA) is a serious and rare hematologic disease that may be fatal if untreated promptly···【More】
Update: 19 Mar,2026Source: BigbearViews: 90
FDA Approves Promacta as First-Line Therapy for Aplastic Anemia

Overview of Severe Aplastic Anemia (SAA)Severe aplastic anemia (SAA) is a serious and rare hematologic disease that may be fatal if untreated promptly···【More】
Update: 19 Mar,2026Source: BigbearViews: 91
Novartis Promacta Becomes the First First-Line Drug for SAA

The immunotherapy drug Promacta (eltrombopag) has recently received FDA approval to expand its label. It is now indicated for use in combination with ···【More】
Update: 13 Feb,2026Source: BigbearViews: 93
FDA Approves Promacta as First-Line Treatment for SAA

Severe Aplastic Anemia (SAA) is a serious and rare blood disorder that can be fatal if not treated promptly; current initial treatments have shown lim···【More】
Update: 13 Feb,2026Source: BigbearViews: 99